AXIM BIOTECHNOLOGIES, INC. Cash And Cash Equivalents At Carrying Value

• AXIM BIOTECHNOLOGIES, INC. showed a decrease of -89.6% in Cash And Cash Equivalents At Carrying Value from 2021 to 2022.
• This data is from AXIM BIOTECHNOLOGIES, INC.'s annual report (Form 10-K), filed with the SEC on April 17, 2023.
• XBRL data for this metric is available from 2010 to 2022 (12 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Quarterly values from 10-Q filings: Q4 2010: $0.00 | Q1 2011: $0.00 | Q2 2011: $0.00 | Q3 2011: $13.1 thousand | Q1 2012: $39.1 thousand | Q2 2012: $1.6 thousand | Q3 2012: $7.5 thousand | Q1 2013: $14.4 thousand | Q2 2013: $145.00 | Q3 2013: $1.2 thousand | Q4 2013: $127.00 | Q3 2014: $949.8 thousand | Q4 2014: $661.1 thousand | Q1 2015: $195.3 thousand | Q3 2015: $43.3 thousand | Q2 2016: $18.6 thousand | Q3 2016: $870.6 thousand | Q2 2017: $4.10 million | Q3 2017: $3.08 million | Q4 2017: $2.06 million | Q1 2018: $725.6 thousand | Q2 2018: $515.2 thousand | Q3 2018: $632.2 thousand | Q4 2018: $1.81 million | Q1 2019: $2.66 million | Q2 2019: $2.21 million | Q3 2019: $1.17 million | Q4 2019: $511.6 thousand | Q2 2020: $891.4 thousand | Q3 2020: $1.16 million | Q4 2020: $457.2 thousand | Q1 2021: $449.2 thousand | Q2 2021: $202.2 thousand | Q3 2021: $338.4 thousand | Q1 2022: $408.0 thousand | Q2 2022: $65.2 thousand | Q4 2022: $47.3 thousand | Q1 2023: $53.5 thousand.
• Historical annual values: Fiscal year 2022: $47.3 thousand | Fiscal year 2021: $453.0 thousand | Fiscal year 2018: $1.81 million | Fiscal year 2017: $2.06 million | Fiscal year 2016: $713.3 thousand | Fiscal year 2015: $134.2 thousand | Fiscal year 2014: $661.1 thousand | Fiscal year 2013: $127.00 | Fiscal year 2012: $19.1 thousand | Fiscal year 2011: $23.1 thousand | Fiscal year 2010: $0.00 | Fiscal year 2010: $0.00.
• Data sourced from SEC EDGAR public filings as of August 10, 2026.

Last verified: August 10, 2026